Progress Software: AI Risk and Stagnant Revenue Demand Greater Discount

What happened

Progress Software reported adjusted EPS up 13% and adjusted free cash flow up 17%, but revenue declined 2% and annual recurring revenue grew just 1% in constant currency, signaling underlying stagnation. Management emphasizes sticky customers and capacity-based pricing as protective moats, yet the article argues AI disruption, challenges integrating Domo, and added debt reduce confidence in durable growth. The Seeking Alpha author estimates fair value at $34.50, below the $37.50 share price, concluding there is insufficient margin of safety despite a low adjusted P/E. This contrasts with an earlier DeepValue report that saw potential upside from an FCF-based DCF of $63.46, but that view already flagged extreme leverage (net debt/EBITDA 11.6x) and unquantified MOVEit litigation as tail risks. The market now appears to be pricing in slower growth and execution risk rather than a value re-rating.

Implication

The latest financials show cash generation remains solid, but top-line contraction and minimal ARR growth suggest the installed base is not expanding meaningfully. AI disruption could erode demand for legacy development and infrastructure tools like OpenEdge and Telerik, even if management touts AI-enabled features. The Domo integration adds execution risk and further debt, compounding existing leverage from the ShareFile acquisition and litigation overhang. Given the fair value estimate below market price, the risk-reward is unattractive; any bounce from low valuation could be a selling opportunity unless fundamentals improve. Long-term investors should monitor ARR growth, net debt reduction, and resolution of MOVEit legal liabilities before reconsidering the thesis.

Thesis delta

The prior DeepValue report leaned toward potential accumulation based on a large DCF discount and resilient FCF. New evidence of declining revenue, near-flat ARR, AI disruption concerns, and Domo integration challenges shifts the stance to Hold/Sell. The margin of safety has evaporated as fair value estimates fall below the share price, and leverage plus litigation risks now dominate the narrative.